Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Mar;99(3):477-80.
doi: 10.1111/j.1476-5381.1990.tb12953.x.

The effects of novel vasodilator long chain acyl carnitine esters in the isolated perfused heart of the rat

Affiliations

The effects of novel vasodilator long chain acyl carnitine esters in the isolated perfused heart of the rat

D N Criddle et al. Br J Pharmacol. 1990 Mar.

Abstract

1. The effects of palmitoyl carnitine (PC) and novel derivatives were examined on the isolated Langendorff perfused heart of the rat. 2. Bolus injections of PC (1-300 nmol) produced coronary constriction accompanied by a cumulative irreversible depression of contractility. 3. Prior storage of PC in chloroform containing 2% ethanol in heat-sealed ampoules resulted in production of the ethyl ester of the compound (PCE). This compound was isolated and also synthesized (P1E). In contrast to PC, both PCE and P1E exhibited potent vasodilator activity. 4. Increasing the fatty acid chain length from palmitoyl to stearoyl resulted in a significant reduction in coronary dilator activity of the ester compound, whereas different ester groups did not affect the vasodilator action appreciably. Complete removal of the fatty acid chain abolished all vascular effects at the doses used. 5. The vasodilatation produced by these acyl carnitine esters was comparable to that produced by several known vasodilator drugs including verapamil, cromakalim, amyl nitrate and iloprost; however, the duration of the vasodilator response was more prolonged with the carnitate derivatives.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Pharmacol. 1986 Dec;89(4):749-57 - PubMed
    1. Circ Res. 1986 Feb;58(2):230-40 - PubMed
    1. Circ Res. 1984 Aug;55(2):135-54 - PubMed
    1. J Clin Invest. 1981 Apr;67(4):1232-6 - PubMed
    1. J Biol Chem. 1979 Dec 25;254(24):12404-10 - PubMed

MeSH terms

LinkOut - more resources